Proton Pump Inhibitors (PPIs), like all drugs, cause adverse drug events. Given the sheer number of patients prescribed, or using over-the-counter, PPIs, many practitioners may question continued use. Hear as Geoff examines a recent study from Ann Arbor which looked at the effects of a deprescribing program to step down from PPIs.

Redeem your CPE or CME credit here by getting a GameChangers Subscription!

References and resources:
N/A

Continuing Education Information:
Learning Objectives:
1. Discuss a recent study evaluating the risks of proton pump inhibitors
2. Identify potential patients that could benefit from proton pump inhibitor discontinuation

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-232-H01-P
Initial release date: 8/10/21
Expiration date: 8/10/22
Complete CPE & CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram